As PRMT5 inhibitors affect other protein methylation events, we assessed whether JNJ-64619178 effects on neuroblastoma cell viability were dependent on SNRPD3 in neuroblastoma cells. The gene discussed is PRMT5; the disease is neuroblastoma.